The global PACS market is expected to grow from USD 3.5 billion in 2018 to USD 5.2 billion by 2030, at a CAGR of 4.6% during the forecast period. The growth of the market can be attributed to factors such as increasing adoption of digital imaging technology and rising demand for advanced healthcare services across the globe.
The global PACS market is segmented on the basis of type, delivery mode, imaging modality, usage model, application and region. On the basis of type, it is classified into hosted PACS (clouhosted), onsite (premise) PACS and hybrid PACS; on the basis of delivery mode it is classified into single departmental PACs and multi-departmental PACs; on the basis of imaging modality it is classified into angiography, mammography, computed tomography (CT), digital fluoroscopy (DF), digital radiography (DR), magnetic resonance imaging (MRI), nuclear imaging and ultrasound; based on usage model it is classified as enterprise PACs or cardiology PACs or radiology PACs; based on application it is classified as enterprise applications or cardiology applications or radiology applications; based on region it covers North America, Latin America Europe Asia Pacific Middle East & Africa regions.
Some Of The Growth Factors Of This Market:
- Increasing demand for digital imaging and storage solutions.
- Increasing number of hospitals and clinics.
- Growing adoption of electronic health records.
Industry Growth Insights published a new data on “Vendor Neutral Archive (VNA) and PACS Market”. The research report is titled “Vendor Neutral Archive (VNA) and PACS Market research by Types (by Delivery Mode, Cloud-hosted, On-Site (Premise), Hybrid, by Imaging Modality, Angiography, Mammography, Computed Tomography, Digital Fluoroscopy, Digital Radiography, Magnetic Resonance Imaging, Nuclear Imaging, Ultrasound, Other, by Usage Model, Single Department, Multiple Departments, Multiple Sites, Vendor Neutral Archive (VNA) and PAC), By Applications (Enterprise, Cardiology, Radiology), By Players/Companies Agfa Healthcare NV, Dell Technologies, Fujifilm Holdings Corporation, GE Healthcare, IBM Corporation, Koninklijke Philips NV, Lexmark International, McKesson Corporation, Novarad Corporation, Siemens, TeraMedica, Merge Health, BridgeHead, Carestream Health, Vendor Neutral Archive (VNA) and PAC”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Vendor Neutral Archive (VNA) and PACS Market Research Report
By Type
by Delivery Mode, Cloud-hosted, On-Site (Premise), Hybrid, by Imaging Modality, Angiography, Mammography, Computed Tomography, Digital Fluoroscopy, Digital Radiography, Magnetic Resonance Imaging, Nuclear Imaging, Ultrasound, Other, by Usage Model, Single Department, Multiple Departments, Multiple Sites, Vendor Neutral Archive (VNA) and PAC
By Application
Enterprise, Cardiology, Radiology
By Companies
Agfa Healthcare NV, Dell Technologies, Fujifilm Holdings Corporation, GE Healthcare, IBM Corporation, Koninklijke Philips NV, Lexmark International, McKesson Corporation, Novarad Corporation, Siemens, TeraMedica, Merge Health, BridgeHead, Carestream Health, Vendor Neutral Archive (VNA) and PAC
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
 and PACS Industry Outlook.svg)
Global Vendor Neutral Archive (VNA) and PACS Market Report Segments:
The global Vendor Neutral Archive (VNA) and PACS market is segmented on the basis of:
Types
by Delivery Mode, Cloud-hosted, On-Site (Premise), Hybrid, by Imaging Modality, Angiography, Mammography, Computed Tomography, Digital Fluoroscopy, Digital Radiography, Magnetic Resonance Imaging, Nuclear Imaging, Ultrasound, Other, by Usage Model, Single Department, Multiple Departments, Multiple Sites, Vendor Neutral Archive (VNA) and PAC
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Enterprise, Cardiology, Radiology
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Agfa Healthcare NV
- Dell Technologies
- Fujifilm Holdings Corporation
- GE Healthcare
- IBM Corporation
- Koninklijke Philips NV
- Lexmark International
- McKesson Corporation
- Novarad Corporation
- Siemens
- TeraMedica
- Merge Health
- BridgeHead
- Carestream Health
- Vendor Neutral Archive (VNA) and PAC
 and PACS Market Overview.svg)
Highlights of The Vendor Neutral Archive (VNA) and PACS Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- by Delivery Mode
- Cloud-hosted
- On-Site (Premise)
- Hybrid
- by Imaging Modality
- Angiography
- Mammography
- Computed Tomography
- Digital Fluoroscopy
- Digital Radiography
- Magnetic Resonance Imaging
- Nuclear Imaging
- Ultrasound
- Other
- by Usage Model
- Single Department
- Multiple Departments
- Multiple Sites
- Vendor Neutral Archive (VNA) and PAC
- By Application:
- Enterprise
- Cardiology
- Radiology
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Vendor Neutral Archive (VNA) and PACS Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 and PACS Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The Vendor Neutral Archive (VNA) is a repository of electronic resources that can be used by libraries and other information professionals. The PACS is an online catalog of library resources that are available to the general public.
Some of the major companies in the vendor neutral archive (vna) and pacs market are Agfa Healthcare NV, Dell Technologies, Fujifilm Holdings Corporation, GE Healthcare, IBM Corporation, Koninklijke Philips NV, Lexmark International, McKesson Corporation, Novarad Corporation, Siemens, TeraMedica, Merge Health, BridgeHead, Carestream Health, Vendor Neutral Archive (VNA) and PAC.
The vendor neutral archive (vna) and pacs market is expected to register a CAGR of 4.6%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Vendor Neutral Archive (VNA) and PACS Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Vendor Neutral Archive (VNA) and PACS Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Vendor Neutral Archive (VNA) and PACS Market - Supply Chain
4.5. Global Vendor Neutral Archive (VNA) and PACS Market Forecast
4.5.1. Vendor Neutral Archive (VNA) and PACS Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Vendor Neutral Archive (VNA) and PACS Market Size (000 Units) and Y-o-Y Growth
4.5.3. Vendor Neutral Archive (VNA) and PACS Market Absolute $ Opportunity
5. Global Vendor Neutral Archive (VNA) and PACS Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Vendor Neutral Archive (VNA) and PACS Market Size and Volume Forecast by Type
5.3.1. by Delivery Mode
5.3.2. Cloud-hosted
5.3.3. On-Site (Premise)
5.3.4. Hybrid
5.3.5. by Imaging Modality
5.3.6. Angiography
5.3.7. Mammography
5.3.8. Computed Tomography
5.3.9. Digital Fluoroscopy
5.3.10. Digital Radiography
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Vendor Neutral Archive (VNA) and PACS Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Vendor Neutral Archive (VNA) and PACS Market Size and Volume Forecast by Application
6.3.1. Enterprise
6.3.2. Cardiology
6.3.3. Radiology
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Vendor Neutral Archive (VNA) and PACS Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Vendor Neutral Archive (VNA) and PACS Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Vendor Neutral Archive (VNA) and PACS Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Vendor Neutral Archive (VNA) and PACS Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Vendor Neutral Archive (VNA) and PACS Demand Share Forecast, 2019-2026
9. North America Vendor Neutral Archive (VNA) and PACS Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Vendor Neutral Archive (VNA) and PACS Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Vendor Neutral Archive (VNA) and PACS Market Size and Volume Forecast by Application
9.4.1. Enterprise
9.4.2. Cardiology
9.4.3. Radiology
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Vendor Neutral Archive (VNA) and PACS Market Size and Volume Forecast by Type
9.7.1. by Delivery Mode
9.7.2. Cloud-hosted
9.7.3. On-Site (Premise)
9.7.4. Hybrid
9.7.5. by Imaging Modality
9.7.6. Angiography
9.7.7. Mammography
9.7.8. Computed Tomography
9.7.9. Digital Fluoroscopy
9.7.10. Digital Radiography
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Vendor Neutral Archive (VNA) and PACS Demand Share Forecast, 2019-2026
10. Latin America Vendor Neutral Archive (VNA) and PACS Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Vendor Neutral Archive (VNA) and PACS Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Vendor Neutral Archive (VNA) and PACS Market Size and Volume Forecast by Application
10.4.1. Enterprise
10.4.2. Cardiology
10.4.3. Radiology
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Vendor Neutral Archive (VNA) and PACS Market Size and Volume Forecast by Type
10.7.1. by Delivery Mode
10.7.2. Cloud-hosted
10.7.3. On-Site (Premise)
10.7.4. Hybrid
10.7.5. by Imaging Modality
10.7.6. Angiography
10.7.7. Mammography
10.7.8. Computed Tomography
10.7.9. Digital Fluoroscopy
10.7.10. Digital Radiography
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Vendor Neutral Archive (VNA) and PACS Demand Share Forecast, 2019-2026
11. Europe Vendor Neutral Archive (VNA) and PACS Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Vendor Neutral Archive (VNA) and PACS Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Vendor Neutral Archive (VNA) and PACS Market Size and Volume Forecast by Application
11.4.1. Enterprise
11.4.2. Cardiology
11.4.3. Radiology
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Vendor Neutral Archive (VNA) and PACS Market Size and Volume Forecast by Type
11.7.1. by Delivery Mode
11.7.2. Cloud-hosted
11.7.3. On-Site (Premise)
11.7.4. Hybrid
11.7.5. by Imaging Modality
11.7.6. Angiography
11.7.7. Mammography
11.7.8. Computed Tomography
11.7.9. Digital Fluoroscopy
11.7.10. Digital Radiography
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Vendor Neutral Archive (VNA) and PACS Demand Share, 2019-2026
12. Asia Pacific Vendor Neutral Archive (VNA) and PACS Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Vendor Neutral Archive (VNA) and PACS Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Vendor Neutral Archive (VNA) and PACS Market Size and Volume Forecast by Application
12.4.1. Enterprise
12.4.2. Cardiology
12.4.3. Radiology
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Vendor Neutral Archive (VNA) and PACS Market Size and Volume Forecast by Type
12.7.1. by Delivery Mode
12.7.2. Cloud-hosted
12.7.3. On-Site (Premise)
12.7.4. Hybrid
12.7.5. by Imaging Modality
12.7.6. Angiography
12.7.7. Mammography
12.7.8. Computed Tomography
12.7.9. Digital Fluoroscopy
12.7.10. Digital Radiography
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Vendor Neutral Archive (VNA) and PACS Demand Share, 2019-2026
13. Middle East & Africa Vendor Neutral Archive (VNA) and PACS Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Vendor Neutral Archive (VNA) and PACS Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Vendor Neutral Archive (VNA) and PACS Market Size and Volume Forecast by Application
13.4.1. Enterprise
13.4.2. Cardiology
13.4.3. Radiology
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Vendor Neutral Archive (VNA) and PACS Market Size and Volume Forecast by Type
13.7.1. by Delivery Mode
13.7.2. Cloud-hosted
13.7.3. On-Site (Premise)
13.7.4. Hybrid
13.7.5. by Imaging Modality
13.7.6. Angiography
13.7.7. Mammography
13.7.8. Computed Tomography
13.7.9. Digital Fluoroscopy
13.7.10. Digital Radiography
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Vendor Neutral Archive (VNA) and PACS Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Vendor Neutral Archive (VNA) and PACS Market: Market Share Analysis
14.2. Vendor Neutral Archive (VNA) and PACS Distributors and Customers
14.3. Vendor Neutral Archive (VNA) and PACS Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Agfa Healthcare NV
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Dell Technologies
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Fujifilm Holdings Corporation
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. GE Healthcare
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. IBM Corporation
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Koninklijke Philips NV
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Lexmark International
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. McKesson Corporation
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Novarad Corporation
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Siemens
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. TeraMedica
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Merge Health
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. BridgeHead
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Carestream Health
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Vendor Neutral Archive (VNA) and PAC
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
